Patent and Exclusivity Search Results from query on Appl No 021071 Product 002 in the OB_Rx list.

Patent Data

Appl
No		 Prod
No		 Patent
No		 Patent
Expiration		 Drug Substance
Claim		 Drug Product
Claim		 Patent Use
Code		 Delist
Requested
021071 002 5002953 Sep 17, 2011 Y Y U-329
021071 002 5002953 Sep 17, 2011 Y Y U-628
021071 002 5002953 Sep 17, 2011 Y Y U-840
021071 002 5002953*PED Mar 17, 2012
021071 002 5741803 Apr 21, 2015 Y Y U-329 Y
021071 002 5741803 Apr 21, 2015 Y Y U-628 Y
021071 002 5741803*PED Oct 21, 2015
021071 002 6288095 Feb 11, 2017 U-420 Y
021071 002 6288095*PED Aug 11, 2017
021071 002 7358366 Apr 19, 2020 Y
021071 002 7358366*PED Oct 19, 2020

Exclusivity Data

There is no unexpired exclusivity for this product.

Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.

View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page

FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:
    Orange Book Data - Monthly
    Generic Drug Product Information & Patent Information - Daily
    Orange Book Data Updated Through October, 2009
    Patent and Generic Drug Product Data Last Updated: November 20, 2009